Synapse - Advanced Practice Providers

Results (66)

Impact of pre-transplant rituximab on efficacy of revaccination of lymphoma patients after autologous hematopoietic stem cell transplantation

Meeting Abstract

Preston, E. V.; Palazzo, M. A.; Seier, K.; Devlin, S. M.; Giralt, S.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
Blood (2018)

Fulltext@MSK | Save

Burden and impact of geriatric syndromes associated with allogeneic hematopoietic cell transplantation in older adults

Meeting Abstract

Lin, R. J.; Elko, T. A.; Hilden, P.; Dahi, P. B.; Jakubowski, A. A.; Perales, M. A.; Barker, J.; Castro-Malaspina, H. R.; Shaffer, B. C.; Shahrokni, A.; more...
Blood (2018)

Fulltext@MSK | Save

Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia

Meeting Abstract

Preston, E. V.; Chinapen, S.; Borrill, T.; Davis, E.; Shaffer, B. C.; Tamari, R.; Jakubowski, A. A.; Perales, M. A.; Ponce, D. M.; Shah, G. L.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Outpatient foscarnet administration incorporating home infusions is feasible greatly enhancing the care of hematopoietic stem cell transplant recipients

Meeting Abstract

Beyer, K.; Abboud, M.; Hambright, K.; Lin, A.; Proli, A. J.; Bhatt, V.; Castillo, C.; Ponce, D. M.; Barker, J. N.; Perales, M. A.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
Blood (2017)

Fulltext@MSK | Save

A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
Blood (2017)

Fulltext@MSK | Save

Prospective evaluation of unrelated donor cord blood and haploidentical donor access reveals graft availability varies by patient ancestry: Practical implications for donor selection

Journal Article

Kosuri, S.; Wolff, T.; Devlin, S. M.; Byam, C.; Mazis, C. M.; Naputo, K.; Davis, E.; Paulson, J.; Nhaissi, M.; Wells, D. S.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
Blood (2016)

Fulltext@MSK | Save

Prospective evaluation of cord blood (CB) and haplo-identical (haplo) donor availability reveals compromised donor access for both CB and haplo grafts in minority patients

Meeting Abstract

Kosuri, S.; Wolff, T.; Lauer, E.; Byam, C.; Yoo, Y.; Davis, E.; Paulson, J.; Sideroff, M.; Wells, D. S.; Perales, M. A.; more...
Biology of Blood and Marrow Transplantation (2016)

Fulltext@MSK | Save